Synchrony Financial Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Synchrony Financial operates as a premier consumer financial services company, providing credit products through partnerships with national and regional retailers, healthcare providers, and other merchants. The company operates through a single business segment organized into five sales platforms: Home & Auto, Digital, Diversified & Value, Health & Wellness, and Lifestyle.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Earnings | $757 million | $1,293 million |
| Net Interest Income | $4,464 million | $4,405 million |
| Provision for Credit Losses | $1,491 million | $1,884 million |
| Purchase Volume | $40.7 billion | $42.4 billion |
| Loan Receivables (Period-End) | $99.6 billion | $101.7 billion |
| Net Charge-Off Rate (Annualized) | 6.38% | 6.31% |
| Allowance Coverage Ratio | 10.87% | 10.72% |
| Return on Assets (Annualized) | 2.5% | 4.4% |
| Return on Equity (Annualized) | 18.4% | 35.6% |
| Total Deposits | $83.4 billion | $83.0 billion (Dec 2024) |
Material Changes vs. Prior Period
- Net Earnings Decline: Net earnings decreased to $757 million from $1.3 billion in Q1 2024. The primary driver was the absence of an $802 million after-tax gain on the sale of Pets Best recorded in the prior year. This was partially offset by a $393 million decrease in the provision for credit losses.
- Revenue Mix: Net interest income increased 1.3% to $4.5 billion, driven by a 6.6% reduction in interest expense due to lower benchmark rates. However, "Other income" dropped significantly to $149 million from $1.2 billion, largely due to the prior year's Pets Best gain.
- Credit Quality: Over-30 day delinquencies improved to 4.52% (down 22 basis points year-over-year). However, the net charge-off rate increased slightly to 6.38%. The allowance coverage ratio increased to 10.87%.
- Portfolio Volume: Loan receivables decreased 2.1% year-over-year to $99.6 billion, reflecting lower purchase volume and seasonal trends. Purchase volume declined 3.9% to $40.7 billion.
- Capital Actions: The company repurchased $600 million of common stock and completed its prior repurchase program. In April 2025, a new $2.5 billion repurchase program was authorized, and the quarterly dividend was increased to $0.30 per share.
Guidance, Outlook, and Risks
- Regulatory Update: The Consumer Financial Protection Bureau (CFPB) final rule on credit card late fees, which was challenged in court, was vacated by the court on April 15, 2025. Synchrony plans to review product and pricing changes made in anticipation of the rule.
- Seasonality: The company notes typical seasonal fluctuations, with loan receivables peaking in late December and declining in the first half of the year. This seasonality impacts delinquency metrics and allowance levels.
- Liquidity and Capital: Liquidity remains strong with $23.8 billion in liquid assets. The company maintains a "well-capitalized" status under Basel III rules. The CECL regulatory capital transition adjustment is now fully phased-in as of March 31, 2025.
- Key Risks: Risks include macroeconomic conditions (inflation, interest rates), concentration of revenue in a small number of partners, cyber-security threats, and regulatory changes. The company also faces risks related to the accuracy of credit loss models and the ability to securitize loan receivables.
Investor Verification Checklist
- Exclusion of One-Time Gains: Verify the impact of the $1.1 billion pre-tax gain from the Pets Best sale in Q1 2024 on year-over-year earnings comparisons.
- Credit Loss Methodology: Review the changes in the Allowance for Credit Losses methodology adopted in Q1 2025 (shift to statistical account-level modeling) and its impact on future provisions.
- Regulatory Capital Transition: Confirm the full phase-in of the CECL regulatory capital transition adjustment and its effect on capital ratios moving forward.
- Shareholder Returns: Note the completion of the prior buyback program and the terms of the new $2.5 billion authorization announced in April 2025.
- Deposit Funding: Monitor the stability of the deposit base, which represented 83% of total funding sources, and the cost of funds relative to benchmark rates.